tiprankstipranks
Trending News
More News >
Photronics (PLAB)
NASDAQ:PLAB

Photronics (PLAB) AI Stock Analysis

Compare
699 Followers

Top Page

PLAB

Photronics

(NASDAQ:PLAB)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - 5.2)
Rating:78Outperform
Price Target:
$37.00
▲(12.02% Upside)
Action:ReiteratedDate:02/27/26
The score is led by strong financial quality—especially an exceptionally conservative balance sheet and solid profitability—supported by constructive technical trends. Offsetting factors are only moderate valuation (P/E ~18.6 with no dividend yield provided) and execution/visibility risks highlighted on the earnings call, including short backlog, seasonally softer Q2 guidance, and elevated CapEx.
Positive Factors
Balance sheet strength
Photronics' essentially zero leverage and expanding assets/equity provide durable financial flexibility. Low debt reduces refinancing and solvency risk during semiconductor cycles, enables funding of multi-year capacity builds and strategic initiatives without forcing dilutive financing, and supports steady investment.
High‑end IC technology leadership
Consecutive records in high‑end IC sales indicate growing share in premium mask segments where ASPs and margins are higher. Leadership on advanced nodes and qualifications for sub‑20nm work reinforces a structural advantage, helping sustain superior mix, pricing power, and long-term margin resilience versus mainstream competitors.
Strong operating cash flow and reinvestment
Robust operating cash conversion funds aggressive CapEx and regional expansion plans without heavy external financing. Consistent cash generation supports multi-quarter equipment installs and customer qualifications, preserving execution optionality and enabling Photronics to scale high‑end capacity that drives long‑term revenue and margin improvement.
Negative Factors
Very short backlog
A 1–3 week backlog creates persistent revenue and margin volatility: small swings in customer orders or high‑end book‑ins can materially move quarterly results. Short visibility complicates capacity planning and weakens forward revenue predictability during multi‑quarter equipment installs and qualification cycles.
Elevated capital expenditure
Large, near‑term CapEx raises depreciation and fixed costs before new capacity is revenue‑producing. If customer qualifications and ramp timing slip, higher depreciation and lower free cash flow conversion (TTM FCF ~24% of net income) could compress margins and reduce short‑term financial flexibility.
Mainstream price competition in China
Rising local competition in mainstream masks risks sustained pricing pressure and share erosion in volume segments. Even with a high‑end focus, persistent margin compression in the mainstream market can weigh on consolidated margins and limit upside from high‑end growth if scale economics deteriorate.

Photronics (PLAB) vs. SPDR S&P 500 ETF (SPY)

Photronics Business Overview & Revenue Model

Company DescriptionPhotronics, Inc., together with its subsidiaries, engages in the manufacture and sale of photomask products and services in the United States, Taiwan, Korea, Europe, China, and internationally. The company offers photomasks that are used in the manufacture of integrated circuits and flat panel displays (FPDs); and to transfer circuit patterns onto semiconductor wafers, FDP substrates, and other types of electrical and optical components. It sells its products to semiconductor and FPD manufacturers, designers, and foundries, as well as to other high-performance electronics manufacturers through its sales personnel and customer service representatives. The company was formerly known as Photronic Labs, Inc. and changed its name to Photronics, Inc. in 1990. Photronics, Inc. was incorporated in 1969 and is based in Brookfield, Connecticut.
How the Company Makes MoneyPhotronics generates revenue primarily through the sale of photomasks to semiconductor and display manufacturers. The company's revenue model is based on the production and delivery of high-precision photomasks that are tailored to specific customer needs. Key revenue streams include sales from standard photomask products, custom photomasks designed for advanced technology nodes, and the provision of related services such as engineering support and design assistance. Significant partnerships with leading semiconductor companies allow Photronics to secure long-term contracts and leverage economies of scale, contributing to its overall earnings. Additionally, as technology continues to advance with the push for smaller and more efficient chips, Photronics benefits from increased demand for its high-end photomask solutions, aligning with industry trends towards miniaturization and enhanced performance.

Photronics Earnings Call Summary

Earnings Call Date:Feb 25, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:May 27, 2026
Earnings Call Sentiment Positive
The call presents a generally positive operational and financial performance: revenue growth, record high-end IC sales, strong margins, and robust operating cash flow. Management has clear strategic initiatives—technology leadership, geographic expansion (U.S., Korea), and prioritized high-end opportunities—that support future growth. Near-term cautions include a seasonal Q2 revenue dip due to Chinese New Year, limited order visibility (1–3 week backlog), capacity constraints until expansions and qualifications complete, elevated fiscal 2026 CapEx (which will raise depreciation), and competitive pressure in China’s mainstream segment. On balance, the positives (growth, record high-end demand, strong profitability and cash generation, and clear expansion strategy) outweigh the near-term headwinds and execution risks.
Q1-2026 Updates
Positive Updates
FPD Performance and Technology Leadership
FPD revenue of $60.0M, up 3% year-over-year. Installed a most-advanced mask writer in Korea enabling G8.6 AMOLED capability — first supplier with this tool — positioning the company for higher ASP opportunities as G8.6 adoption broadens.
Strong Profitability and EPS
Gross margin at 35% (high end of expectations) and operating margin of 24%. GAAP diluted EPS of $0.74 and non-GAAP diluted EPS (ex-FX) of $0.61 per share, both above expectations.
Robust Operating Cash Flow and Liquidity
Operating cash flow of $97.0M (second highest quarter ever), representing 43% of revenue. Total cash and short-term investments increased by $49.0M sequentially to $637.0M (includes $459.0M held in joint ventures).
Reiterated Capital Investment Plan and Expansion Roadmap
Reiterated fiscal 2026 CapEx guidance of $330.0M; Q1 CapEx $48.0M focused on FPD equipment and special projects. Ongoing expansion projects in the U.S. (Allen) and Korea expected to enter volume production in 2027 to capture regionalization and outsourcing trends.
Strategic Positioning on Advanced Nodes and Regionalization
Supporting advanced logic (12/14nm, extending to 8nm and below) and advanced DRAM qualifications for patterns below 20nm. Management is prioritizing high-end opportunities and geographic diversification to capitalize on onshoring and design/manufacturing regionalization.
Revenue Growth and Beat
Total revenue of $225.0M in fiscal Q1, up 4% sequentially and 6% year-over-year, exceeding expectations.
IC Segment Strength and Record High-End Sales
IC revenue of $165.0M, up 7% year-over-year; record high-end IC revenue of $71.0M, up 19% year-over-year, marking the second consecutive quarterly record and driving improved mix and operating leverage.
Negative Updates
Near-Term Seasonal Headwind and Q2 Revenue Guidance Decline
Fiscal Q2 revenue guidance of $212.0M–$220.0M implies a sequential decline versus Q1 (~2.2% to 5.8% lower than $225.0M), with management attributing the shortfall primarily to the Chinese New Year holiday impact and related temporary slowdown.
Limited Visibility and Order Volatility
Company notes inherently variable demand with typical backlog of only 1–3 weeks; high-end mask orders carry materially higher ASPs, meaning small order changes can significantly swing revenue and earnings.
Capacity Constraints and Timing of Expansion Benefits
High-end capacity is currently constrained (need to maximize Boise output); Allen facility and other expansions require equipment installation and customer qualification before contributing — volume production timing is multi-quarter and some projects not online until 2027.
Elevated CapEx Could Pressure Near-Term Financials
Elevated fiscal 2026 CapEx guidance of $330.0M (Q1 CapEx $48.0M) will increase future depreciation and requires execution to translate into higher revenue; management acknowledges continuous review of CapEx relative to demand.
Competitive Pressure in China Mainstream Segment
Local Chinese entrants are increasing competition in mainstream segments; while management sees high-end as less penetrable, mainstream pricing/competition could affect stabilized mainstream economics.
Potential for Margin Variability as Capacity and Mix Change
Management cautioned that margins fluctuate with product mix and that as capacity comes online and product mix shifts, current elevated margins may normalize; risk that margins could decline if mix or pricing dynamics change.
Company Guidance
For fiscal Q2 the company guided revenue of $212 million to $220 million, an operating margin of 22%–24% and non‑GAAP diluted EPS of $0.49–$0.55, citing a modest seasonal impact from Chinese New Year and limited visibility with typical backlog of only 1–3 weeks (and noting high‑end orders carry materially higher ASPs). For context, fiscal Q1 revenue was $225 million (up 4% sequentially, 6% year‑over‑year), with IC revenue $165 million (up 7% YoY) including record high‑end IC revenue of $71 million (up 19%), FPD revenue $60 million (up 3% YoY), gross margin at 35% (high end of expectations), operating margin 24%, GAAP diluted EPS $0.74 and non‑GAAP diluted EPS $0.61; operating cash flow was $97 million (43% of revenue) and Q1 CapEx was $48 million, while full‑year fiscal 2026 CapEx remains at $330 million; total cash and short‑term investments rose to $637 million (including $459 million in JVs, 50.1% ownership), and the company reiterated elevated CapEx plans to expand high‑end capacity.

Photronics Financial Statement Overview

Summary
Strong overall fundamentals driven by a standout balance sheet (near-zero debt, expanding assets/equity) and solid profitability. The main offset is weaker recent free-cash-flow conversion versus prior years, despite positive operating cash flow.
Income Statement
78
Positive
TTM (Trailing-Twelve-Months) revenue is up strongly (+152.2%), while profitability remains solid with ~35.3% gross margin, ~26.1% operating margin, and ~16.1% net margin. However, margins have softened versus prior years (e.g., operating margin ~30.3% in 2023 and ~28.6% in 2024), and annual revenue growth was slightly negative in 2024 and 2025, pointing to some cyclicality and recent volatility despite the sharp TTM rebound.
Balance Sheet
93
Very Positive
The balance sheet is a major strength: debt is minimal (TTM total debt ~$0.02M) against a large equity base (~$1.65B), resulting in essentially no leverage. Assets (~$1.90B TTM) and equity have expanded meaningfully versus prior years, and returns on equity are healthy (~12.1% TTM), though below the stronger level seen in 2022 (~14.3%). Overall, financial flexibility is excellent with limited balance-sheet risk.
Cash Flow
70
Positive
Cash generation is positive with TTM operating cash flow of ~$266.6M, comfortably covering net income (about 1.49x). The main weakness is conversion to free cash flow: TTM free cash flow is ~$65.9M and only ~24% of net income, down sharply from stronger free cash flow generation in 2022–2024 (roughly ~50–59% of net income). TTM free cash flow growth is very high (+1,066.5%), but it is coming off a weaker prior period and remains well below earlier peak levels.
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue862.22M849.29M866.95M892.08M824.55M663.76M
Gross Profit303.00M299.83M315.95M336.16M294.21M167.04M
EBITDA295.73M299.39M330.55M351.21M321.22M194.09M
Net Income136.49M136.41M130.69M125.48M118.79M55.45M
Balance Sheet
Total Assets1.90B1.80B1.71B1.53B1.32B1.29B
Cash, Cash Equivalents and Short-Term Investments636.87M588.16M640.67M512.21M358.50M276.67M
Total Debt21.00K5.96M22.96M26.53M45.62M117.21M
Total Liabilities251.50M207.23M231.30M250.61M253.74M293.64M
Stockholders Equity1.21B1.17B1.12B975.01M831.53M823.69M
Cash Flow
Free Cash Flow65.92M59.66M130.50M170.88M162.85M41.50M
Operating Cash Flow266.59M247.80M261.44M302.18M275.19M150.77M
Investing Cash Flow-286.02M-238.90M-156.47M-101.55M-147.76M-103.49M
Financing Cash Flow-94.03M-115.26M-7.73M-18.49M-38.69M-53.90M

Photronics Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price33.03
Price Trends
50DMA
35.57
Negative
100DMA
30.81
Positive
200DMA
25.86
Positive
Market Momentum
MACD
-0.57
Positive
RSI
42.55
Neutral
STOCH
25.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PLAB, the sentiment is Neutral. The current price of 33.03 is below the 20-day moving average (MA) of 36.80, below the 50-day MA of 35.57, and above the 200-day MA of 25.86, indicating a neutral trend. The MACD of -0.57 indicates Positive momentum. The RSI at 42.55 is Neutral, neither overbought nor oversold. The STOCH value of 25.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PLAB.

Photronics Risk Analysis

Photronics disclosed 1 risk factors in its most recent earnings report. Photronics reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Photronics Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$1.95B12.1511.84%-2.04%8.84%
62
Neutral
$1.90B47.894.13%-3.90%-41.66%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
$1.77B56.384.96%4.48%-3.62%-20.33%
57
Neutral
$2.55B-6.51-24.06%6.65%-4652.36%
56
Neutral
$1.43B-11.04-28.80%7.53%22.97%
55
Neutral
$1.29B-14.78-9.07%-4.50%-45.79%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PLAB
Photronics
33.03
12.27
59.10%
COHU
Cohu
27.48
10.95
66.24%
HIMX
Himax Technologies
10.13
1.79
21.48%
MXL
Maxlinear
16.50
4.09
32.96%
UCTT
Ultra Clean Holdings
56.06
31.56
128.82%
VECO
Veeco
31.46
10.16
47.70%

Photronics Corporate Events

Business Operations and StrategyExecutive/Board Changes
Photronics Consolidates Leadership with Key Executive Promotions
Positive
Jan 13, 2026

On January 12, 2026, Photronics reshaped its senior leadership team, appointing Chief Financial Officer Eric Rivera as president while he continues as principal financial officer, promoting Rui (Elie) Zhang to chief accounting officer with continued responsibilities as corporate controller, and naming Todd Alesio senior vice president and chief administrative officer while he remains head of global human resources. Announced publicly on January 13, 2026, the appointments are positioned by Chairman and CEO George Macricostas as a move to sharpen organizational clarity and reinforce accountability across key finance and administrative functions, signaling a consolidation of leadership roles designed to support the company’s execution under its existing management approach rather than a change in strategic direction.

The most recent analyst rating on (PLAB) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Photronics stock, see the PLAB Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Photronics Expands Board, Appoints Independent Finance Executive
Positive
Jan 7, 2026

On January 1, 2026, Photronics expanded its board of directors from eight to nine members and appointed finance executive Michelle Almeida as an independent director, a move the company announced publicly on January 7, 2026. Almeida, currently vice president of corporate finance and treasurer at Compass Datacenters, brings more than 25 years of experience in treasury and financial planning and analysis, and will receive compensation in line with other non-employee directors, though she has not yet been assigned to any board committees; the appointment underscores Photronics’ effort to deepen financial and strategic expertise at the board level as it pursues its long-term strategy, without any disclosed related-party transactions or special arrangements tied to her election.

The most recent analyst rating on (PLAB) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Photronics stock, see the PLAB Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Photronics announces CTO transition and leadership changes
Neutral
Jan 2, 2026

On January 2, 2026, Photronics announced that Executive Vice President and Chief Technology Officer Dr. Christopher J. Progler stepped down from his position effective December 29, 2025, concluding more than two decades of service in which he played a pivotal role in shaping the company’s technology strategy and strengthening its competitive position in integrated circuit and flat panel display photomask markets. Under the terms of his employment agreement, Progler will receive severance equal to one year of base salary, continued medical and dental coverage for 360 days, and accrued obligations, and he is considering an advisory role to support continuity on strategic priorities, as Photronics underscores its intention to maintain disciplined operational execution and long-term value creation for shareholders despite the leadership transition.

The most recent analyst rating on (PLAB) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Photronics stock, see the PLAB Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 27, 2026